Elicio Therapeutics, Inc. Investment Income, Interest
Elicio Therapeutics, Inc. (ELTX) reported Investment Income, Interest of $138.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- Elicio Therapeutics, Inc. investment income, interest for the quarter ending 2026-06-30 was $138.00K, a 17.86% decline year-over-year.
- Elicio Therapeutics, Inc. investment income, interest for the quarter ending 2026-03-31 was $157.00K, a 25.24% decline year-over-year.
- Elicio Therapeutics, Inc. investment income, interest for the quarter ending 2025-09-30 was $199.00K, a 7.57% increase year-over-year.
- Elicio Therapeutics, Inc. investment income, interest for the quarter ending 2025-06-30 was $168.00K, a 22.63% increase year-over-year.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month |
|---|---|---|---|
| 2026-06-30 | $138.00K 10-Q · filed 2026-08-13 | $295.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $157.00K 10-Q · filed 2026-05-11 | ||
| 2025-09-30 | $199.00K 10-Q · filed 2025-11-13 | $367.00K derived: sum of 2 quarters · filed 2026-08-13 | $577.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $168.00K 10-Q · filed 2026-08-13 | $378.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $210.00K 10-Q · filed 2026-05-11 | ||
| 2024-09-30 | $185.00K 10-Q · filed 2025-11-13 | $322.00K derived: sum of 2 quarters · filed 2025-11-13 | $472.00K 10-Q · filed 2025-11-13 |
| 2024-06-30 | $137.00K 10-Q · filed 2025-08-07 | $287.00K 10-Q · filed 2025-08-07 | |
| 2023-09-30 | $246.00K 10-Q · filed 2024-11-13 | $285.00K derived: sum of 2 quarters · filed 2024-11-13 | $298.00K 10-Q · filed 2024-11-13 |
| 2023-06-30 | $39.00K 10-Q · filed 2024-08-13 | $51.00K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |